|
|
DYD B-11
|
|
 |
GyjWWcYVRQWsASIYiq |
 |
116 |
|
 |
| Hello good day http://12yo.icu 14yo The use of these drugs in combination is investigational, the company said, and is not approved anywhere else. European review of the MAA submission for trametinib, both as monotherapy and in combination with dabrafenib, is ongoing. CHMP has reverted from the accelerated assessment review process to standard timelines to allow sufficient time for review of the submission. |
|
 |
Caden |
 |
2019-05-23 07:39:09 |
|
|
|
|
|
|
|
|
|
